Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−7.65 USD
−49.23 M USD
0.00 USD
About ImageneBio, Inc.
Sector
Industry
CEO
Kristin Yarema
Website
Headquarters
San Diego
Founded
2016
FIGI
BBG00XZY4TG9
Ikena Oncology discovers and develops biomarker-driven therapies for cancer patients. The company focuses on developing novel cancer therapies that drive the formation and spread of cancer. Ikena Oncology provides medical needs by discovering chemistry, translational science, and patient-centric drug development.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of IMA is 15.74 USD — it has decreased by −6.96% in the past 24 hours. Watch ImageneBio, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange ImageneBio, Inc. stocks are traded under the ticker IMA.
IMA stock has fallen by −91.67% compared to the previous week, the month change is a −92.05% fall, over the last year ImageneBio, Inc. has showed a −93.57% decrease.
We've gathered analysts' opinions on ImageneBio, Inc. future price: according to them, IMA price has a max estimate of 276.00 USD and a min estimate of 276.00 USD. Watch IMA chart and read a more detailed ImageneBio, Inc. stock forecast: see what analysts think of ImageneBio, Inc. and suggest that you do with its stocks.
IMA stock is 7.49% volatile and has beta coefficient of 0.85. Track ImageneBio, Inc. stock price on the chart and check out the list of the most volatile stocks — is ImageneBio, Inc. there?
Yes, you can track ImageneBio, Inc. financials in yearly and quarterly reports right on TradingView.
ImageneBio, Inc. is going to release the next earnings report on Nov 6, 2025. Keep track of upcoming events with our Earnings Calendar.
IMA net income for the last quarter is −2.77 M USD, while the quarter before that showed −8.62 M USD of net income which accounts for 67.90% change. Track more ImageneBio, Inc. financial stats to get the full picture.
No, IMA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jul 29, 2025, the company has 10 employees. See our rating of the largest employees — is ImageneBio, Inc. on this list?
Like other stocks, IMA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ImageneBio, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ImageneBio, Inc. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ImageneBio, Inc. stock shows the strong sell signal. See more of ImageneBio, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.